Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2003
11/27/2003WO2002063010A3 Method of producing recombinant antibodies against tumors
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003US20030220487 Flea peritrophin nucleic acid molecules, proteins and uses thereof
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220475 Neutralizing immunogenic hev polypepetides
11/27/2003US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
11/27/2003US20030220285 Expression vectors for stimulating an immune response and methods of using the same
11/27/2003US20030220276 HIV vaccine and method of use
11/27/2003US20030220270 Mono-and disaccharide derivatives
11/27/2003US20030220265 Dihydroxypropyl cysteine peptide and agent containing this peptide
11/27/2003US20030220241 Method of treating cancer
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219873 Self-assembling recombinant papillomavirus capsid proteins
11/27/2003US20030219861 Preparing libraries of chimeric immunoglobulins which demonstrate increased specificity and are comprised of framework regions (FR) and for use as diagnostic and therapeutic tools; genetic vaccines; gene therapy
11/27/2003US20030219860 Comprises nucleotide sequences coding novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
11/27/2003US20030219857 Preparing protein cross-linking enzymes for use in food processing and drug delivevry
11/27/2003US20030219853 Method of cross-linking a compound
11/27/2003US20030219826 Comprises amino acid sequence for treating arthritic, inflammatory and apoptosis disorders; mimetics
11/27/2003US20030219789 36P6D5: secreted tumor antigen
11/27/2003US20030219768 Lung cancer therapeutics and diagnostics
11/27/2003US20030219732 Adaptation sites of porcine reproductive and respiratory syndrome virus
11/27/2003US20030219475 Preservation of bioactive materials by freeze dried foam
11/27/2003US20030219473 A lipid based cochelate formed of a purified soy- based phospholipid such as soy phosphatidylserine, and a multivalent cation selected from calcium, magnesium and zinc
11/27/2003US20030219460 Cotton rat lung cells for virus culture
11/27/2003US20030219459 Fusion proteins; epitopes; microarrays; vaccines
11/27/2003US20030219458 Multivalent vaccination using recombinant adenovirus
11/27/2003US20030219457 Derived from Clostridium proteins; immunogens; fusion proteins; vaccines
11/27/2003US20030219455 Antigens, polynucleotides; kits
11/27/2003US20030219454 Isolated from Haemophilus paragallinarum; for vaccinating chickens against infectious coryza
11/27/2003US20030219453 Vaccines
11/27/2003US20030219452 HIV envelope V3-CCR5 binding site immunogen
11/27/2003US20030219451 Stable helical C peptides and uses therefor
11/27/2003US20030219450 Tat/rev/vpr/nef genes/proteins for vaccines
11/27/2003US20030219449 Glycoproteins for screening animals; vaccines; gene therapy kits
11/27/2003US20030219448 Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
11/27/2003US20030219444 Genes and encoded polypeptides expressed in cancer cells, used for diagnosis, prophylaxis and as targets of tumors; vaccines
11/27/2003US20030219442 Human monoclonal antibodies to influenza M2 protein and methods of making and using same
11/27/2003US20030219439 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003US20030219437 Administering antibodies used as antagonists to CD antigen ligands on the cells, for prophylaxis of cardiovascular, gastrointestinal or urogenital disorders
11/27/2003US20030219436 Immobilized and soluble forms of CD antigens used for immunology modulation, prophylaxis of inflammation, autoimmune diseases, graft versus host disease and cancer
11/27/2003US20030219435 Method of reducing an immune response to a recombinant virus
11/27/2003US20030219434 Antibodies for cancer therapy and diagnosis
11/27/2003US20030219426 Endostatins used as antiproliferative agents or angiogenesis inhibitors for prophylaxis of tumors, or as contraceptives
11/27/2003US20030219424 Polynucleotide codes for amino acid sequences used for medical diagnosis, prophylaxis autoimmune diseases, as antiallergens or antitumor agents
11/27/2003US20030219420 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/27/2003US20030219419 Alteration of cell membrane for new functions
11/27/2003US20030219409 Eukaryotic gene expression cassette and uses thereof
11/27/2003US20030219403 Compositions and methods of tolerizing a primate to an antigen
11/27/2003US20030219382 Cancer-linked gene as target for chemotherapy
11/27/2003US20030219381 Animal model for infection by an apicomplexan parasite
11/27/2003US20030219376 Progression elevated Gene-3 and uses thereof
11/27/2003CA2830619A1 Glucan-based vaccines
11/27/2003CA2812019A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2727830A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma
11/27/2003CA2526895A1 Regulated attenuation of live vaccines to enhance cross protective immunogenicity
11/27/2003CA2525646A1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene
11/27/2003CA2511604A1 Treatment of cancer by the use of anti fas antibody
11/27/2003CA2494359A1 Bcg vaccine and utilization thereof
11/27/2003CA2486147A1 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
11/27/2003CA2485983A1 Cancer-linked gene as target for chemotherapy
11/27/2003CA2485847A1 Glucan-based vaccines
11/27/2003CA2485453A1 Polypeptide antigen inducing hiv neutralizing antibodies
11/27/2003CA2484719A1 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
11/27/2003CA2484295A1 Attenuation of metapneumovirus
11/27/2003CA2483712A1 Use of modified novirhabdoviruses to obtain vaccines
11/27/2003CA2483640A1 Fusion protein of hiv regulatory/accessory proteins
11/27/2003CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2481783A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/26/2003EP1365246A1 Diagnostics and therapeutics for diseases associated with neuromedin U2 receptor (NMU2)
11/26/2003EP1365034A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
11/26/2003EP1365030A1 G-protein coupled receptor marker molecules associated with colorectal lesions
11/26/2003EP1364969A2 Human tissue factor related DNA segments, polypeptides and antibodies
11/26/2003EP1364962A1 Use of monocarboxylate transporter proteins for thyroid hormone transport
11/26/2003EP1364657A1 Remedies for tumor in hematopoietic organs
11/26/2003EP1364031A1 Hiv-like particles and the use thereof
11/26/2003EP1364025A1 A novel gene bn01 mapping to chromosome 16q24.3
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364021A2 Compositions and methods relating to colon specific genes and proteins
11/26/2003EP1364017A2 Inflammation related g-protein coupled receptor
11/26/2003EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/26/2003EP1364010A2 Immunomodulatory polynucleotides and methods of using the same
11/26/2003EP1364006A2 Methods to identify mutant cells with altered sialic acid
11/26/2003EP1363996A2 Epothilone resistant cell lines
11/26/2003EP1363950A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors
11/26/2003EP1363948A1 Polypeptide of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids coding therefor and use thereof
11/26/2003EP1363943A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/26/2003EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof
11/26/2003EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene
11/26/2003EP1363939A2 Peptides for use in the treatment of alzheimer's disease
11/26/2003EP1363938A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
11/26/2003EP1363930A1 A method for generating genetically altered antigens
11/26/2003EP1363929A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/26/2003EP1363674A2 Agents and methods for treating pain
11/26/2003EP1363672A1 Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines
11/26/2003EP1363670A1 Polynucleotide formulation for enhanced intracellular transfer
11/26/2003EP1363666A1 Methods for treating disease states comprising administration of low levels of antibodies
11/26/2003EP1363665A2 Vaccine
1 ... 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 ... 1823